Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality &

Status Active, not recruiting

Clinical Trial Summary

The primary objective is to determine whether continuous sensing, control and mitigation of home indoor air quality influences the frequency of asthma related symptoms, as measured by Serum IgE, Spirometry with exhaled Nitric Oxide, missed school and workdays, need for pharmacologic intervention (albuterol, oral steroids), frequency of sick visits to pulmonologist or primary care provider (PCP), urgent care / emergency department visits, and hospitalizations

Clinical Trial Description

Participants will be in the research study for approximately 2 years. There will be 11 visits to the clinic for monitoring of asthma symptoms and pulmonary function and 16 interval contacts with research staff made by either telephone or email to monitor asthma symptoms. There will also be 5 visits to participants' homes by technicians from Emerson Climate Technologies and/or an electrician in cooperation with Emerson. During these visits Emerson employees will assess participants' homes to determine if they qualify for the study and install study equipment to monitor air quality for the first half of the study and monitor and mitigate air quality for the second half of the study. At the end of the study, the technicians and/or electrician from Emerson will reset the study equipment or replace participants' original equipment, if that is their wish. Participants will be enrolled in the research study for approximately 2 years. The first year, technicians from the study sponsor will install indoor air quality monitoring equipment in the participants' homes and information about the air quality in their home as well as baseline health and asthma information will be collected. This will be done through continuous sensing via an Atmocube air quality sensor, and a portable air quality sensor, the Atmotube. Beginning in the second half of the study, mitigation strategies of a smart home thermostat, the Sensi Touch Smart Thermostat, a smart bath fan control, the Enbrighten Z-wave Switch, and high quality furnace filter, 3M Filtrete MPR 2800 Ultrafine Particle Reduction Air Filter, will be employed. Information about the participants' asthma, health status, and air quality in the homes will continue to be collected. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05843045
Study type	Interventional
Source	Dayton Children's Hospital
Contact
Status	Active, not recruiting
Phase	N/A
Start date	August 18, 2023
Completion date	January 12, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02513160` - Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma	Phase 3
Active, not recruiting	`NCT02883530` - Refractory Asthma Stratification Programme (RASP) Bronchoscopy Study
Completed	`NCT02003521` - Impact of Lung Flute Therapy on Asthma	N/A
Completed	`NCT01253603` - Efficacy, Safety, and Pharmacokinetics of QAW039	Phase 2
Completed	`NCT01845025` - Study of Safety of Foradil in Patients With Persistent Asthma	Phase 4
Not yet recruiting	`NCT02053402` - Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital	Phase 4
Completed	`NCT01078688` - Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma	N/A
Completed	`NCT01156844` - Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol	Phase 2
Completed	`NCT02176694` - Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care	N/A
Completed	`NCT02026336` - E-nose and Inflammatory Asthma Phenotypes	N/A
Withdrawn	`NCT04271839` - Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients	Phase 4
Active, not recruiting	`NCT04480242` - Asthma Research in Children and Adolescents
Completed	`NCT02175771` - Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma	Phase 3
Completed	`NCT01147510` - Asthma Control in Elderly Patients With Montelukast	Phase 4
Completed	`NCT03541187` - Cockroach Immunotherapy in Children and Adolescents	Phase 2
Completed	`NCT02040779` - A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma — IAQ

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms